Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021980
Company: ALCON LABS INC
Company: ALCON LABS INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| FLUORESCITE | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS | Prescription | AP | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 03/28/2006 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | PRIORITY |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021980s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021980s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021980s000TOC.html |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 06/10/2026 | SUPPL-12 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021980s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/021980Orig1s012ltr.pdf | |
| 11/17/2021 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021980Orig1s007lbl.pdf | |
| 02/09/2015 | SUPPL-6 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 02/12/2014 | SUPPL-5 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 02/02/2016 | SUPPL-4 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021980s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021980Orig1s004ltr.pdf |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 06/10/2026 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021980s012lbl.pdf | |
| 11/17/2021 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021980Orig1s007lbl.pdf | |
| 02/02/2016 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021980s004lbl.pdf | |
| 03/28/2006 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021980s000lbl.pdf |
FLUORESCITE
INJECTABLE;INTRAVENOUS; EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| AK-FLUOR 10% | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS | Prescription | Yes | AP | 022186 | LONG GROVE PHARMS |
| FLUORESCEIN SODIUM | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 220046 | BPI LABS |
| FLUORESCEIN SODIUM | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 215709 | NEXUS |
| FLUORESCEIN SODIUM | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 218651 | ZYDUS LIFESCIENCES |
| FLUORESCITE | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS | Prescription | Yes | AP | 021980 | ALCON LABS INC |